112 related articles for article (PubMed ID: 15039174)
1. FDG positron emission tomography of bone involvement in sarcoidosis.
Aberg C; Ponzo F; Raphael B; Amorosi E; Moran V; Kramer E
AJR Am J Roentgenol; 2004 Apr; 182(4):975-7. PubMed ID: 15039174
[No Abstract] [Full Text] [Related]
2. Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy.
Ludwig V; Fordice S; Lamar R; Martin WH; Delbeke D
Clin Nucl Med; 2003 Mar; 28(3):176-9. PubMed ID: 12592122
[TBL] [Abstract][Full Text] [Related]
3. FDG PET in the clinical evaluation of sarcoidosis with bone lesions.
Kobayashi A; Shinozaki T; Shinjyo Y; Kato K; Oriuchi N; Watanabe H; Takagishi K
Ann Nucl Med; 2000 Aug; 14(4):311-3. PubMed ID: 11023033
[TBL] [Abstract][Full Text] [Related]
4. FDG PET/CT in bone sarcoidosis.
Grozdic Milojevic I; Sobic-Saranovic D; Videnovic-Ivanov J; Saranovic D; Odalovic S; Artiko V
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Mar; 33(1):66-74. PubMed ID: 27055838
[TBL] [Abstract][Full Text] [Related]
5. Osseous Sarcoidosis Mimicking Metastatic Cancer on Positron Emission Tomography.
Ashamalla M; Koutroumpakis E; McCarthy L; Hegener P; Grimm R; Mehdi S
J Oncol Pract; 2016 Jul; 12(7):697-8. PubMed ID: 27407163
[No Abstract] [Full Text] [Related]
6. Central skeletal sarcoidosis mimicking metastatic disease.
Talmi D; Smith S; Mulligan ME
Skeletal Radiol; 2008 Aug; 37(8):757-61. PubMed ID: 18401580
[TBL] [Abstract][Full Text] [Related]
7. FDG-positron emission tomographic imaging in carcinoma of the breast: interference by massive sarcoidosis.
Garcia CA; Rosenberg RJ; Spencer RP
Clin Nucl Med; 2003 Mar; 28(3):218-9. PubMed ID: 12592129
[No Abstract] [Full Text] [Related]
8. Monitoring the Therapy of Extensive Osseous Sarcoidosis With FDG PET/CT.
Yang H; Numani S; Liu S
Clin Nucl Med; 2017 Jul; 42(7):e337-e339. PubMed ID: 28240658
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
[TBL] [Abstract][Full Text] [Related]
10. Clinical images: Bone sarcoidosis mimicking multiple metastases.
Mosnier E; Siles P; Ebbo M; Bernit E; Veit V; Tintignac A; Chagnaud C; Harlé JR; Schleinitz N
Arthritis Rheum; 2011 Jun; 63(6):1542. PubMed ID: 21630244
[No Abstract] [Full Text] [Related]
11. Bone and bone marrow involvement in sarcoidosis.
Yachoui R; Parker BJ; Nguyen TT
Rheumatol Int; 2015 Nov; 35(11):1917-24. PubMed ID: 26248533
[TBL] [Abstract][Full Text] [Related]
12. Cervical and axillary lymph node sarcoidosis misdiagnosed as lymphoma on F-18 FDG PET-CT.
Li YJ; Zhang Y; Gao S; Bai RJ
Clin Nucl Med; 2007 Mar; 32(3):262-4. PubMed ID: 17314619
[No Abstract] [Full Text] [Related]
13. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
Teirstein AS; Machac J; Almeida O; Lu P; Padilla ML; Iannuzzi MC
Chest; 2007 Dec; 132(6):1949-53. PubMed ID: 17925421
[TBL] [Abstract][Full Text] [Related]
14. Reticuloendothelial system involvement in untreated sarcoidosis patients as assessed by 18F-FDG PET scanning.
Kalkanis A; Judson MA; Kalkanis D; Vavougios GD; Malamitsi J; Georgou E
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):423-425. PubMed ID: 28079858
[TBL] [Abstract][Full Text] [Related]
15. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.
Aide N; Benayoun M; Kerrou K; Khalil A; Cadranel J; Talbot JN
Br J Radiol; 2007 Mar; 80(951):e67-71. PubMed ID: 17548505
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis.
Nishiyama Y; Yamamoto Y; Fukunaga K; Takinami H; Iwado Y; Satoh K; Ohkawa M
J Nucl Med; 2006 Oct; 47(10):1571-6. PubMed ID: 17015889
[TBL] [Abstract][Full Text] [Related]
17. Nivolumab-Associated Pulmonary and Bone Sarcoidosis in a Patient With Melanoma of Unknown Primary.
Tulbah RI; Rowe SP; Solnes LB; Javadi MS
Clin Nucl Med; 2019 Sep; 44(9):e519-e521. PubMed ID: 31348077
[TBL] [Abstract][Full Text] [Related]
18. Imaging features of sarcoidosis on MDCT, FDG PET, and PET/CT.
Prabhakar HB; Rabinowitz CB; Gibbons FK; O'Donnell WJ; Shepard JA; Aquino SL
AJR Am J Roentgenol; 2008 Mar; 190(3 Suppl):S1-6. PubMed ID: 18287458
[TBL] [Abstract][Full Text] [Related]
19. F-18 FDG PET: mottled splenomegaly with remission of symptoms after splenectomy in sarcoidosis.
Vento JA; Arici M; Spencer RP; Sood R
Clin Nucl Med; 2004 Feb; 29(2):103-4. PubMed ID: 14734908
[No Abstract] [Full Text] [Related]
20. [Usefulness of FDG-PET for monitoring the effects of therapy in sarcoidosis patients].
Kaira K
Nihon Kokyuki Gakkai Zasshi; 2009 Dec; 47(12):1166; author reply 1167. PubMed ID: 20058699
[No Abstract] [Full Text] [Related]
[Next] [New Search]
